Sponsored by:

Nuclear Medicine: Page 232

Devicor buys Neoprobe's gamma detection line
By AuntMinnie.com staff writers
Breast cancer treatment technology provider Devicor Medical Products has inked a deal to acquire the gamma detection devices portfolio of Neoprobe.
May 25, 2011
Varian inks pact with Auckland UniServices
By AuntMinnie.com staff writers
Centella Therapeutics, a subsidiary of Varian Medical Systems, and Auckland UniServices have signed a licensing agreement granting Centella exclusive rights to CEN-209.
May 24, 2011
FDG-PET helps assess TB treatment
By AuntMinnie.com staff writers
FDG-PET scans can help determine earlier whether treatment for tuberculosis (TB) is working or the disease is multidrug-resistant, according to a study in the June issue of the Journal of Nuclear Medicine.
May 23, 2011
AECL inspecting repairs to NRU
By AuntMinnie.com staff writers
Atomic Energy of Canada Limited (AECL) this week began a month-long shutdown at its Chalk River, Ontario, nuclear facility to inspect repairs made to the National Research Universal (NRU) reactor in August 2010.
May 19, 2011
PET scanner shows early breast cancer
By AuntMinnie.com staff writers
European researchers say they have developed a clinical PET system with enhanced resolution and the sensitivity to detect breast cancer in its early stages.
May 19, 2011
Gambhir named to head Stanford radiology
By AuntMinnie.com staff writers
Molecular imaging researcher Dr. Sanjiv "Sam" Gambhir, PhD, has been named chair of the department of radiology at Stanford University. Gambhir replaces Dr. Gary Glazer, who led the department for 24 years and plans to retire this year.
May 18, 2011
Medrad launches new version of Intego PET
By AuntMinnie.com staff writers
Contrast injector technology firm Medrad has launched the next generation of its Intego PET radiopharmaceutical infusion system, which features a new design that is 38% smaller and includes enhancements to technologist workflow.
May 18, 2011
Lantheus touts flurpiridaz F-18 results
By AuntMinnie.com staff writers
Lantheus Medical Imaging is touting positive results from a phase II clinical trial of its PET radiopharmaceutical for use in detecting coronary artery disease.
May 16, 2011
IsoRay nets revenue gain in Q3
By AuntMinnie.com staff writers
A 21% increase in patient cases helped medical isotope developer IsoRay Medical to a third-quarter revenue gain and a lower net loss compared to the same quarter of the prior year.
May 16, 2011
Naviscan partners for sales in China
By AuntMinnie.com staff writers
PET developer Naviscan has partnered with Chindex Medical for sales and service of Naviscan's positron emission mammography scanners in China.
May 12, 2011
IBA revenues increase by 20% in Q1
By AuntMinnie.com staff writers
Radiopharmaceutical developer Ion Beam Applications (IBA) reported nearly 20% revenue growth in its first quarter.
May 11, 2011
FEC-PET/CT helps direct radiation to prostate tumors
By Wayne Forrest
F-18 fluoroethylcholine (FEC) with PET/CT is showing early promise for radiation treatment planning of recurrent and primary prostate cancer, with greater doses of radiation delivered to PET/CT-positive lymph nodes, according to a study published online May 1 in Radiation Oncology.
May 11, 2011
Previous Page
Page 232 of 440
Next Page